Weight Loss Drug Causing Pulmonary Hypertension

Weight Loss Drug Causing Pulmonary Hypertension
Weight Loss Drugs

Weight Loss Drugs

Fenfluramine was marketed by American Home Products later known as Wyeth as Pondimin, but was shown to cause potentially fatal pulmonary hypertension and heart valve problems, which eventually led to its withdrawal and legal damages of over $13 billion. Phentermine was not shown to have harmful effects..Other weight loss drugs have also been associated with medical complications, such as fatal pulmonary hypertension and heart valve damage due to Redux and Fen-phen, and hemorrhagic stroke due phenylpropanolamine. Many of these substances are related to amphetamine..

The drug combination fenfluramine/phentermine, usually called fen-phen, was an anti-obesity treatment that utilized two anorectics. Fenfluramine was marketed by American Home Products later known a . Washington, DC Fen-Phen, at one time a miracle weight loss drug that have cause to worry, as primary pulmonary hypertension can show up .Appetite-suppressant drugs and the risk of primary pulmonary hypertension that anorexigen use is currently the overwhelming cause of PPH symptoms occur in spite of weight loss is a reason for alarm and should trigger investigation.. Last month, the agency OK 'd Belviq, the first new weight loss drug and caused a condition in some patients called pulmonary hypertension, .

Comments